t
GSK plc's Board has decided to re-appoint Deloitte LLP as its external auditor from the financial year ending 31 December 2028, following a competitive tender process. A resolution for this re-appointment will be put to GSK's shareholders for approval at the Company's 2028 Annual General Meeting. Deloitte LLP was initially appointed as GSK's external auditor with effect from the financial year ended 31 December 2018.
| Date | 17 Jul 2026 |
| Time | 12:00:01 |
| Category | Miscellaneous |
| ID | 8181M |
Issued: 17 July 2026, London UK
Audit tender conclusion
GSK plc today announces that, after the conclusion of a competitive tender process led by the Audit & Risk Committee, the Board has decided to re-appoint Deloitte LLP (Deloitte) as GSK's external auditor from the financial year ending 31 December 2028.
As a Public Interest Entity, GSK is required to tender the statutory audit every 10 years and rotate every 20. The Company initially appointed Deloitte as external auditor with effect from the financial year ended 31 December 2018.
A resolution to re-appoint Deloitte as GSK's external auditor with effect from the 2028 financial year will be put to GSK's shareholders for approval at the Company's 2028 Annual General Meeting.
Further details of this competitive tender process will be included in GSK's 2026 Annual Report.
V A Whyte
Company Secretary
17 July 2026
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
Registered in England & Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG